Vikram Kansra Selected Research

Biomarkers (Surrogate Marker)

1/2022

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vikram Kansra Research Topics

Disease

10	Nausea 10/2019 - 09/2015
10	Vomiting 10/2019 - 09/2015
5	Neoplasms (Cancer) 01/2022 - 07/2012
3	Infections 01/2015 - 01/2013
3	Chronic Hepatitis C 01/2015 - 01/2013
2	Headache (Headaches) 01/2019 - 09/2015
1	Inflammation (Inflammations) 12/2023
1	Colitis 12/2023
1	Malignant Mesothelioma 01/2022
1	Dizziness (Lightheadedness) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Dyspepsia (Indigestion) 09/2015
1	Constipation 09/2015
1	Hiccup (Hiccups) 09/2015
1	Neutropenia 09/2015
1	Chronic Hepatitis B 01/2015
1	Virus Diseases (Viral Diseases) 01/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2012
1	Multiple Myeloma 07/2012

Drug/Important Bio-Agent (IBA)

11	rolapitantIBA 10/2019 - 09/2015
9	Neurokinin-1 Receptor AntagonistsIBA 10/2019 - 12/2017
5	AntiemeticsIBA 03/2019 - 01/2018
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 07/2012
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 10/2019 - 09/2015
2	peginterferon lambda-1aIBA 01/2015 - 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023
1	tazemetostatIBA 01/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	niraparibIBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Digoxin (Digitek)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2015
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 09/2015
1	NivolumabIBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	Monoclonal AntibodiesIBA 01/2013
1	LigandsIBA 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 07/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2012
1	beta-2 Adrenergic ReceptorsIBA 07/2012
1	Bortezomib (Velcade)FDA Link 07/2012
1	GlucocorticoidsIBA 07/2012
1	Melphalan (Alkeran)FDA LinkGeneric 07/2012
1	Drug CombinationsIBA 07/2012

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 10/2019 - 09/2015
2	Therapeutics 01/2022 - 07/2012
1	Aftercare (After-Treatment) 01/2022
1	Duration of Therapy 01/2015